C N Robson Selected Research

NU2058

1/2010	Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells.
12/2007	Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C N Robson Research Topics

Disease

25	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2000
12	Neoplasms (Cancer) 01/2019 - 01/2000
6	Carcinogenesis 12/2009 - 05/2001
3	Neoplasm Metastasis (Metastasis) 02/2011 - 01/2000
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2008 - 12/2000
2	Ovarian Neoplasms (Ovarian Cancer) 08/2009 - 08/2008
1	Kidney Neoplasms (Kidney Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2010
1	Ovarian Epithelial Carcinoma 08/2008
1	Metaplasia 10/2000
1	Adenocarcinoma 08/2000
1	Carcinoma (Carcinomatosis) 08/2000
1	Disease Progression 01/2000

Drug/Important Bio-Agent (IBA)

10	AndrogensIBA 02/2011 - 08/2000
8	Hormones (Hormone)IBA 10/2011 - 08/2000
6	Proteins (Proteins, Gene)FDA Link 12/2009 - 12/2001
6	Messenger RNA (mRNA)IBA 08/2008 - 01/2000
5	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2009 - 10/2000
3	EnzymesIBA 08/2013 - 01/2000
3	Androgen Receptors (Androgen Receptor)IBA 09/2007 - 10/2000
2	NU2058IBA 01/2010 - 12/2007
2	MitogensIBA 05/2008 - 12/2004
2	Matrix Metalloproteinases (MMPs)IBA 02/2008 - 01/2000
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2007 - 06/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2006 - 12/2000
2	Fibroblast Growth Factor 8IBA 12/2004 - 05/2003
2	SteroidsIBA 12/2001 - 08/2000
2	Fibroblast Growth Factor 7 FDA Link 08/2001 - 12/2000
1	Cadherins (E-Cadherin)IBA 01/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	VimentinIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	NU6102IBA 01/2010
1	Estrogens (Estrogen)FDA Link 01/2010
1	Cyclin-Dependent Kinase 2IBA 01/2010
1	Small Interfering RNA (siRNA)IBA 01/2010
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2010
1	CyclinsIBA 01/2010
1	purineIBA 01/2010
1	Complementary DNA (cDNA)IBA 08/2009
1	GTP-Binding Proteins (G-Protein)IBA 08/2009
1	GTP Phosphohydrolases (GTPases)IBA 08/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2008
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 05/2008
1	Mitogen-Activated Protein Kinase 7IBA 05/2008
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 05/2008
1	Bone Morphogenetic Protein 6IBA 02/2008
1	Doxycycline (Periostat)FDA LinkGeneric 02/2008
1	Androgen Antagonists (Antiandrogens)IBA 12/2007
1	VA 061 (VA061)IBA 12/2007
1	His(5)-Trp(7)-Tyr(8)- LHRHIBA 09/2007
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 09/2007
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 06/2005
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2004
1	Protein Isoforms (Isoforms)IBA 05/2003
1	Fibroblast Growth Factor 1 (FGF-1)IBA 08/2001
1	CurcuminIBA 05/2001
1	CarcinogensIBA 05/2001
1	benzocycloheptapyridineIBA 05/2001
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 05/2001
1	ImmunosorbentsIBA 12/2000
1	Insulin-Like PeptidesIBA 10/2000
1	MucinsIBA 10/2000
1	LigandsIBA 10/2000
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 10/2000
1	Testosterone CongenersIBA 08/2000
1	PPAR alphaIBA 08/2000
1	miboleroneIBA 08/2000
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2000
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2000
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2000

Therapy/Procedure

7	Therapeutics 01/2019 - 08/2001
1	Castration 08/2013
1	Lasers (Laser) 09/2007
1	Prostatectomy (Retropubic Prostatectomy) 10/2000